369 related articles for article (PubMed ID: 31816069)
1. Access to medicines through health systems in low- and middle-income countries.
Ozawa S; Shankar R; Leopold C; Orubu S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
[TBL] [Abstract][Full Text] [Related]
2. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries.
Perehudoff SK; Alexandrov NV; Hogerzeil HV
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii48-iii57. PubMed ID: 31816073
[TBL] [Abstract][Full Text] [Related]
3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
4. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
5. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
[TBL] [Abstract][Full Text] [Related]
6. Noncommunicable diseases, access to essential medicines and universal health coverage.
Beran D; Pedersen HB; Robertson J
Glob Health Action; 2019; 12(1):1670014. PubMed ID: 31573421
[TBL] [Abstract][Full Text] [Related]
7. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
[TBL] [Abstract][Full Text] [Related]
8. Access to essential medicines in 195 countries: A human rights approach to sustainable development.
Perehudoff SK; Alexandrov NV; Hogerzeil HV
Glob Public Health; 2019 Mar; 14(3):431-444. PubMed ID: 30187828
[TBL] [Abstract][Full Text] [Related]
9. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
10. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
11. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
12. Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries.
Perehudoff K; Demchenko I; Alexandrov NV; Brutsaert D; Ackon A; Durán CE; El-Dahiyat F; Hafidz F; Haque R; Hussain R; Salenga R; Suleman F; Babar ZU
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33353250
[TBL] [Abstract][Full Text] [Related]
13. Pain Treatment Continues To Be Inaccessible for Many Patients Around the Globe: Second Phase of Opioid Price Watch, a Cross-Sectional Study To Monitor the Prices of Opioids.
Pastrana T; Wenk R; Radbruch L; Ahmed E; De Lima L
J Palliat Med; 2017 Apr; 20(4):378-387. PubMed ID: 27923102
[TBL] [Abstract][Full Text] [Related]
14. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
Guan X; Hu H; Man C; Shi L
Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
[TBL] [Abstract][Full Text] [Related]
15. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
Amimo F; Lambert B; Magit A; Hashizume M
Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
[TBL] [Abstract][Full Text] [Related]
16. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
[TBL] [Abstract][Full Text] [Related]
17. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
[TBL] [Abstract][Full Text] [Related]
18. Universal Access to Essential Medicines: An Evaluation of Nepal's Free Health Care Scheme.
Adhikari SR; Pandey AR; Ghimire M; Thapa AK; Lamsal DK
J Nepal Health Res Counc; 2018 Mar; 16(1):36-42. PubMed ID: 29717287
[TBL] [Abstract][Full Text] [Related]
19. Are essential medicines in Malaysia accessible, affordable and available?
Saleh K; Ibrahim MI
Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
[TBL] [Abstract][Full Text] [Related]
20. Essential medicines for universal health coverage.
Wirtz VJ; Hogerzeil HV; Gray AL; Bigdeli M; de Joncheere CP; Ewen MA; Gyansa-Lutterodt M; Jing S; Luiza VL; Mbindyo RM; Möller H; Moucheraud C; Pécoul B; Rägo L; Rashidian A; Ross-Degnan D; Stephens PN; Teerawattananon Y; 't Hoen EF; Wagner AK; Yadav P; Reich MR
Lancet; 2017 Jan; 389(10067):403-476. PubMed ID: 27832874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
